uniQure B.V. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (21)

Latest Posts

About This Stock More About This Stock
3 Gene Therapy Stocks Investors Can Bet On In Rest Of 2018
Article By: Zacks Investment Research
Friday, July 13, 2018 3:05 AM EDT
Innovation holds the key in the pharma/biotech sector and most companies have been diverting their resources to develop gene therapy candidates in their goal of finding a cure for difficult and incurable diseases.
In this article: BOLD, QURE, AXON Also: NVS, PFE, SLDB
Read
10 Hot Small Caps Primed For A Winning Streak (Part I)
Article By: TipRanks
Sunday, July 1, 2018 10:11 AM EDT
Despite market jitters, there is one group of stocks that continue to outperform. That’s small caps. Indeed, year-to-date the Russell 2000 small cap index is up 7%. This is versus the S&P 500 which is up only 1.67%.
In this article: GTN, MTW, HIIQ, PRMW, QURE
Read
Biotech Stocks Emerge Unscathed And Ready To Go
Article By: Tarun Chandra, CFA
Friday, May 18, 2018 8:41 PM EDT
The biotech stocks have been demonstrating strong resilience in the face of intense volatility since February and, remarkably, keeping pace with the broader indexes, considering the highly speculative and volatile nature of the group.
In this article: CVS, MRK, IBB, INCY, ESRX, XBI, ARNA, ECYT, IMMU, IRWD, DVAX, SUPN, SRPT, AGIO, QURE, HRTX, LOXO, ATRA, BGNE, ADAP, CRSP, CBIO, GTHX, MRTX
Read
UniQure - Chart Of The Day
Article By: Jim Van Meerten
Thursday, April 12, 2018 4:50 PM EDT
Since the Trend Spotter signaled a buy on 4/10 the stock gained 7.29%.
In this article: QURE
Read
UniQure Announces Closing Of Its Public Offering
Article By: NASDAQ GlobeNewswire
Friday, October 27, 2017 4:57 PM EDT
UniQure N.V., today announced the closing of its underwritten public offering of 5,000,000 of its ordinary shares at a public offering price of $18.25 per share.
In this article: QURE
Read

PARTNER HEADLINES

Latest Tweets for $QURE

No tweets yet!